Code details & principles for
Code | Description | Chapter/Sub-Chapter | Code Specific Guidance |
---|---|---|---|
BT270 | Insertion and removal of radioactive agent (brachytherapy) into carcinoma of the oesophagus, bronchus or stomach | 11.1.0 Oesophagus, 20.0.0 Radiotherapy, 8.1.0 Oesophagus |
CCSD Code (unacceptable combination) | Narrative (unacceptable combination) | Date Code Added |
---|---|---|
BT260 | Planning for insertion and removal of radioactive agent (brachytherapy) into carcinoma of the oesophagus, bronchus or stomach | Pre 2025 |
E4990 | Panendoscopy +/- incisional biopsy | Pre 2025 |
E4991 | Therapeutic Panendoscopy +/- excision biopsy, excision or destruction of lesions | Pre 2025 |
G4410 | Therapeutic oesophago-gastro-duodenoscopy (OGD) with insertion of prosthesis | Pre 2025 |
G4430 | Therapeutic oesophago-gastro-duodenoscopy (OGD) with dilatation | Pre 2025 |
G6500 | Diagnostic oesophago-gastro-duodenoscopy (OGD) includes forceps biopsy, biopsy urease test and dye spray | Pre 2025 |
X7014 | Delivery of low dose rate brachytherapy (not otherwise specified) | Pre 2025 |
X7015 | Delivery of high dose rate brachytherapy (not otherwise specified) | Pre 2025 |
These coding principles set out how the authors intend that the codes and narratives within the CCSD Schedule are interpreted and used. The outputs are available to be used by all individual insurers and providers including CCSD and non-CCSD members. Please note that: